These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 7794495)
1. A comparison of susceptibility to five antifungal agents of yeast cultures from burn patients. Still JM; Law EJ; Belcher KE; Spencer SA Burns; 1995 May; 21(3):167-70. PubMed ID: 7794495 [TBL] [Abstract][Full Text] [Related]
2. In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole. Morace G; Manzara S; Dettori G Chemotherapy; 1991; 37(1):23-31. PubMed ID: 2013239 [TBL] [Abstract][Full Text] [Related]
3. In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole. Martín E; Parras P; Lozano MC Chemotherapy; 1992; 38(5):335-9. PubMed ID: 1337508 [TBL] [Abstract][Full Text] [Related]
5. Multicenter comparison of the sensititre YeastOne Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and other yeasts and yeast-like organisms. Espinel-Ingroff A; Pfaller M; Messer SA; Knapp CC; Killian S; Norris HA; Ghannoum MA J Clin Microbiol; 1999 Mar; 37(3):591-5. PubMed ID: 9986817 [TBL] [Abstract][Full Text] [Related]
6. Candida and candidaemia. Susceptibility and epidemiology. Arendrup MC Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246 [TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibilities of sucrose-negative Candida tropicalis, Candida lusitaniae, and Candida norvegensis to amphotericin B, 5-fluorocytosine, miconazole, and ketoconazole. Ahearn DG; McGlohn MS J Clin Microbiol; 1984 Mar; 19(3):412-6. PubMed ID: 6325491 [TBL] [Abstract][Full Text] [Related]
8. Susceptibility of clinical isolates of yeasts to anti-fungal agents. Hussain Qadri SM; Flournoy DJ; Qadri SG; Ramirez EG Mycopathologia; 1986 Sep; 95(3):183-7. PubMed ID: 3773980 [TBL] [Abstract][Full Text] [Related]
9. [Comparative study of two systems for the determination of the sensitivity of yeasts to antifungal agents]. de Montclos M; de Montclos H; Flandrois JP Pathol Biol (Paris); 1992 May; 40(5):495-9. PubMed ID: 1495833 [TBL] [Abstract][Full Text] [Related]
10. In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012. Pfaller MA; Castanheira M; Messer SA; Jones RN Mycoses; 2015 Apr; 58(4):209-14. PubMed ID: 25727853 [TBL] [Abstract][Full Text] [Related]
11. Role of yeasts as nosocomial pathogens & their susceptibility to fluconazole & amphotericin B. Prasad KN; Agarwal J; Dixit AK; Tiwari DP; Dhole TN; Ayyagari A Indian J Med Res; 1999 Jul; 110():11-7. PubMed ID: 10709333 [TBL] [Abstract][Full Text] [Related]
12. [Identification and susceptibility of clinically isolated yeast-like fungi]. Fukuchi K; Tanaka Y; Oguro T; Wakuta R; Sugita M; Takagi Y; Gomi K Rinsho Byori; 1990 Aug; 38(8):931-6. PubMed ID: 2232256 [TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibility of yeasts isolated from patients in intensive care units to fluconazole and amphotericin B during a 3-year period. Kucukates E; Erturan Z; Susever S; Yegenoglu Y APMIS; 2005 Apr; 113(4):278-83. PubMed ID: 15865609 [TBL] [Abstract][Full Text] [Related]
14. In vitro antifungal susceptibility of Candida spp. isolates from patients with chronic periodontitis and from control patients. Ito CY; de Paiva Martins CA; Loberto JC; dos Santos SS; Jorge AO Braz Oral Res; 2004; 18(1):80-4. PubMed ID: 15273792 [TBL] [Abstract][Full Text] [Related]
15. [Antifungal susceptibility among the isolates of yeast from the University Hospital of the Ryukyus]. Ohta C; Yamane N; Nakasone I; Onaga S; Nakamura K Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 2005; 16(2):127-33. PubMed ID: 16536058 [TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibility testing of Candida isolates from clinical specimens to four antifungal agents. Ohkawa M; Tokunaga S; Takashima M; Nishikawa T; Hisazumi H; Fujita S; Wheat RW Chemotherapy; 1990; 36(6):396-402. PubMed ID: 2292203 [TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibility of Trichosporon beigelii to antifungal agents. Perparim K; Nagai H; Hashimoto A; Goto Y; Tashiro T; Nasu M J Chemother; 1996 Dec; 8(6):445-8. PubMed ID: 8981185 [TBL] [Abstract][Full Text] [Related]
18. Study of the susceptibility of yeast isolates of clinical interest to five antifungal agents using the E test. Linares MJ; Muñoz JF; Solís F; Rodríguez FC; Valero A; Casal M Rev Esp Quimioter; 1998 Mar; 11(1):64-9. PubMed ID: 9795292 [TBL] [Abstract][Full Text] [Related]
19. [Synergic effect of 5-fluorocytosine and imidazole derivatives against yeast strains resistant to 5-fluorocytosine]. Mary C; Goudard M; Blancard A; Quilici M; Regli P Ann Biol Clin (Paris); 1989; 47(9):546-9. PubMed ID: 2558599 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of a capacitance method for direct antifungal susceptibility testing of yeasts in positive blood cultures. Chang HC; Chang JJ; Huang AH; Chang TC J Clin Microbiol; 2000 Mar; 38(3):971-6. PubMed ID: 10698982 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]